Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.
- DOI
- 10.3390/ijms23137206
- Published
- 2022 Jun 29
- Container
- International journal of molecular sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ijms23137206,
title = {Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.},
author = {Nguyen MKL and Jose J and Wahba M and Bernaus-Esqué M and Hoy AJ and Enrich C and Rentero C and Grewal T},
year = {2022},
journal = {International journal of molecular sciences},
doi = {10.3390/ijms23137206},
url = {https://doi.org/10.3390/ijms23137206}
}RIS
TY - JOUR TI - Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance. AU - Nguyen MKL AU - Jose J AU - Wahba M AU - Bernaus-Esqué M AU - Hoy AJ AU - Enrich C AU - Rentero C AU - Grewal T PY - 2022 JO - International journal of molecular sciences DO - 10.3390/ijms23137206 UR - https://doi.org/10.3390/ijms23137206 ER -
APA
MKL, N., J, J., M, W., M, B., AJ, H., C, E., C, R., & T, G. (2022). Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.. International journal of molecular sciences. https://doi.org/10.3390/ijms23137206
Source records
- pubmed · retrieved 2026-09-26T11:18:32.497Z